Dr. Christopher Canfield, DO
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- Philadelphia College of Osteopathic Medicine (2018)
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 237
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Medical school: Philadelphia College of Osteopathic Medicine
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
PA license OS022674
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Temple University Hospital Philadelphia, PA
- Jefferson Health- Northeast Philadelphia, PA
Medical groups
- Temple Physicians Inc (156 clinicians)
- Metropolitan Nephrology Associates PC (9 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 237
- Services billed
- 731
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 87 | 44 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 55 | 31 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 14 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 50 payments worth $1,380 in total to this clinician.
| Novo Nordisk Inc | $226 |
|---|---|
| Novartis Pharmaceuticals Corporation | $209 |
| Ardelyx, Inc. | $185 |
| Akebia Therapeutics Inc | $87.15 |
| Bayer HealthCare Pharmaceuticals Inc. | $81.67 |
| Amgen Inc. | $80.53 |
| Calliditas Therapeutics US Inc. | $68.57 |
| Otsuka America Pharmaceutical, Inc. | $62.62 |
| Food and Beverage | $1,380 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.